These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38383981)

  • 1. Prior history of atrial fibrillation and arrhythmic outcomes: Data from the WEARIT-II prospective registry.
    Goldenberg I; Younis A; McNitt S; Klein H; Goldenberg I; Kutyifa V
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):785-793. PubMed ID: 38383981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V; Vermilye K; Daimee UA; McNitt S; Klein H; Moss AJ
    Europace; 2018 Sep; 20(FI2):f225-f232. PubMed ID: 29905788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and clinical consequences of inappropriate shocks experienced by patients wearing a cardioverter-defibrillator.
    Berger JM; Sengupta JD; Bank AJ; Casey SA; Witt D; Sharkey SW; Stanberry LI; Hauser RG
    Heart Rhythm; 2023 Jul; 20(7):970-975. PubMed ID: 37211148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A wearable cardioverter defibrillator with a low false alarm rate.
    Poole JE; Gleva MJ; Birgersdotter-Green U; Branch KRH; Doshi RN; Salam T; Crawford TC; Willcox ME; Sridhar AM; Mikdadi G; Beinart SC; Cha YM; Russo AM; Rowbotham RK; Sullivan J; Gustavson LM; Kivilaid K
    J Cardiovasc Electrophysiol; 2022 May; 33(5):831-842. PubMed ID: 35174572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C; Winter S; Duncker D; Jungbauer CG; Wäßnig NK; Geller JC; Erath JW; Goeing O; Perings C; Ulbrich M; Roser M; Husser D; Gansera LS; Soezener K; Malur FM; Block M; Fetsch T; Kutyifa V; Klein HU
    Clin Res Cardiol; 2021 Jan; 110(1):102-113. PubMed ID: 32377784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM; Hillmann HAK; Proctor T; Kieser M; Scholz E; Zitron E; Katus HA; Thomas D
    Heart Vessels; 2018 Nov; 33(11):1390-1402. PubMed ID: 29721674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I; Tenbrink D; Kovacs B; Dreher TC; Blockhaus C; Klein N; Shin DI; Hijazi M; Rosenkaimer S; Beiert T; Abumayyaleh M; Saguner AM; Kowitz J; Erath JW; Duru F; Mügge A; Aweimer A; Akin I
    Eur J Clin Invest; 2023 Jul; 53(7):e13977. PubMed ID: 36852491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein HU; McNitt S; Zareba W; Goldenberg I
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1307-1313. PubMed ID: 29992590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Shock Asystole in Patients Dying Out of Hospital While Wearing a Cardioverter Defibrillator.
    Berger JM; Sengupta JD; Bank AJ; Casey SA; Sharkey SW; Stanberry LI; Hauser RG
    JACC Clin Electrophysiol; 2023 Aug; 9(8 Pt 1):1333-1339. PubMed ID: 37558289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    Gassanov N; Mutallimov M; Caglayan E; Erdmann E; Er F
    J Cardiol; 2022 Dec; 80(6):573-577. PubMed ID: 35985868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Patients With In-Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator.
    Ellenbogen KA; Wan C; Shavelle DM
    Am J Cardiol; 2018 Jan; 121(2):205-209. PubMed ID: 29153771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.